Single Dose Investigator Initiated Pilot Study to Investigate CYTALUX (Pafolacianine) for Intraoperative Detection of Malignant Tissue in Subjects Undergoing Surgical Resection for Cancer.
Conditions
- Esophageal Cancer
- Gastrointestinal Cancers
- Gynecologic Cancers
Interventions
- DRUG: CYTALUX™ (pafolacianine) injection preoperatively
Sponsor
John Waters
Collaborators